During a live event, Megan Kruse, MD, discussed NCCN guidelines and key therapies for patients with HR-positive metastatic ...

For patients with breast cancer, the brain functional network shows a shift toward a more randomized pattern after neoadjuvant chemotherapy (NAC).

Breast cancer is the most common cancer in women and the second leading cause of cancer-related deaths after lung cancer.

Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ...

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

Global Hyperthermia Cancer Treatment Market is valued at approximately USD 187.1 million in 2023 and is expected to grow at a healthy rate of 6.11% over the forecast period 2024-2032. Request To ...

Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.

Background Flow diversion of acutely ruptured intracranial aneurysms (IAs) is controversial due to high treatment-related complication rates and a lack of supporting evidence. We present clinical and ...

Doctors use many terms to describe your particular type of cancer. Among those terms are “invasive” and “metastatic.” When it comes to breast cancer, invasive and metastatic both refer to ...

Even when initial treatment leads to remission, the chance of triple-negative breast cancer (TNBC) recurrence remains higher than in other breast cancers. Recurrence rates after standard conventional ...

breast cancer, colon cancer, and prostate cancer. Chemotherapy and radiation treatments for cancer also can lead to anemia, as can nutrition problems, internal blood loss, and certain medications like ...